More on PHARMAC and tobacco control in New Zealand [11]

New Zealand Medical Journal

Volumn 119, Issue 1228, 2006, Pages

  Metcalfe, Scott ^a   Moodie, Peter ^a  

^a PHARMAC ^*  (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; NORTRIPTYLINE;

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG EFFICACY; FINANCIAL MANAGEMENT; HUMAN; LETTER; NEW ZEALAND; NICOTINE REPLACEMENT THERAPY; SIDE EFFECT; SMOKING CESSATION PROGRAM; TOBACCO DEPENDENCE; VALIDATION PROCESS;

EID: 31844436766     PISSN: 11758716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Metcalfe S, Moodie P, McNee W, Holt S, Harwood M, Aldington S, Beasley R, Frizelle F. PHARMAC and tobacco control in New Zealand: two licensed funded options are already available (with responses by Holt et al and the Editor). N Z Med J 2005;118(1217). URL: http://www.nzma.org.nz/journal/118-1217/1544/
2. Hall SM, Humfleet GL, Reus VI, et al. Psychological intervention and antidepressant treatment in smoking cessation. Arch Gen Psychiatry. 2002;59:930-6.
3. Zyban (bupropion) et sevrage tabagique: 1047 observations en un an d'effects indésirables en France. Rev Prescrire December 2003;25:832. Available online: URL: http://www.prescrire.org/bin/cqp/?id=23023 Accessed January 2006.
4. Bupropion: a German Review. Prescrire International 2005;14:103. Translated from Rev Prescrire 2005;25:297.
5. Hughes JR, Stead LF, Lancaster TR. Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 1, 2002 Oxford: Update Software.
6. Holt S, Harwood M, Aldington S, Beasley R. PHARMAC and tobacco control in New Zealand: government policy 'up in smoke'. N Z Med J. 2005;118(1216). URL: http://www.nzma.org.nz/journal/118-1216/1502/
7. Wagena EJ, Knipschild P, Zeegers MP. Should nortriptyline be used as a first-line aid to help smokers quit? Results from a systematic review and meta-analysis. Addiction. 2005;100:317-26.